AAADV Workshop

AAADV is an educational initiative or FDA, academics, advocates, and industry focused on speeding cancer treatment to patients. Sept. 28-Oct. 1, 2021.

[AAADV Workshop @AAADV_Workshop]

Register for the 17th Annual Accelerating Anticancer Agent Development and Validation (AAADV) Workshop! The workshop, featuring speakers from @US_FDA, @ASCO, @theNCI, and more will take place on 9/28-10/1. Register here: https://t.co/TNVBjiJyDG

[AAADV Workshop @AAADV_Workshop]

Dr. Ned Sharpless is presenting live now! Tune in to hear insights from the Director of @theNCI. @NCIDirector @NCICancerCtrl @AAADV_Workshop #AAADV #AAADV2021

[AAADV Workshop @AAADV_Workshop]

Live now: Bill Cance @AmerCancerCMSO of @ACS_Research moderating a discussion between Adrian Hernandez and Michael J. Kelley of @DukeCancer, @pkluetz of @US_FDA, Leanne Madre of @CTTI_Trials, and Steven Piantadosi of @danafarber on the future of #ClinicalTrials. Tune in! #AAADV

[Ishwaria Mohan Subbiah, MD MS FASCO @IshwariaMD]

Final day of 2021 @AAADV_Workshop: now up, @AmerCancerCMSO introducing Keynote Speech with Sir Richard Peto discussing Large-scale Randomized Evidence in the 2020’s.

[AAADV Workshop @AAADV_Workshop]

#RichardPeto's keynote speech is live! Tune in to hear from one of the world's most recognized epidemiologists now. #AAADV #AAADV2021

[AAADV Workshop @AAADV_Workshop]

@a_annapragada, @KunleOdunsiMD, Adekunle Odunsi, Kevin Howcroft of @theNCI, @MDAndersonNews's Andrew Sikora, and Alan Hutson held an IOTN breakout session on the progress and future of #CancerCare #Innovation. Great to bring together these presenters for a riveting discussion.

[AAADV Workshop @AAADV_Workshop]

Sir Richard Peto, Professor of Medical Statistics and Epidemiology at @UniofOxford, will be presenting his keynote speech in just a few minutes. Tune in now! #AAADV #AAADV2021

[AAADV Workshop @AAADV_Workshop]

Day 4 of the AAADV conference is live! As we wrap up this year's conference, we are excited to hear @DavidFajgenbaum, author of "Chasing my Cure". #AAADV #AAADV2021

[AAADV Workshop @AAADV_Workshop]

Former @FDACommissioner @markmcclellan will present alongside @MarianneHLo, Robert Saunders, @NMahendraratnam, Brent Rice, and Jeff Allen of @CancerResrch during tomorrow's @DukeMargolis satellite session: "Value in Cancer Care." See you there! #AAADV #AAADV2021 #AAADV21

[AAADV Workshop @AAADV_Workshop]

Dr. Renzo Canetta, Dr. Nicole Gormley of @US_FDA, @DrOlaLandgren, Kelly Laschinger, Dr. Lisa Meier McShane of @theNCI, and William F. Symmans of @MDAndersonNews shed light on Measurable Residual Disease #MRD and pathologic Complete Response and #pCR earlier today. More tomorrow!

[AAADV Workshop @AAADV_Workshop]

Technology is moving forward, and so are #ClinicalTrials. Dr. Jaap Verweij of @cddf_eu, @drdonsdizon of @LifespanIO, @DrDawnHershman, @SeanKhozin of @ASCO, and @_bakulpatel of @US_FDA discussed this topic today during #AAADV2021. Tune in tomorrow for more discussions.

[AAADV Workshop @AAADV_Workshop]

Earlier today, @a_annapragada of @TexasChildrens, Kory Hallett of @thenci, Dan Watkins, Dr. Casey Cunningham, and Debra Chao of @abbvie provided insights on fundable translational projects. Exciting to bring stakeholders together across sectors to collaborate during #AAADV!

[Jarushka Naidoo @DrJNaidoo]

#AAADV21
Translational IO Safety Science session on the @MGHCancerCenter severe immunotherapy complications service led by @kreynoldsMD

This service is a comprehensive program tailored to address predictors, biomarkers, and mechanisms of irAEs

@NCICTEP_ClinRes

[Jarushka Naidoo @DrJNaidoo]

#AAADV21 Translational IO Safety Science session

Featuring two Irish☘️ presenters alongside @MGHCancerCenter & @DanaFarber... clinician & patient advocate team from @cancertrials_ie lung group @DrJNaidoo & @CotterSeamus 🇮🇪

@LungCommunity @IrishLungCancer @IrishCancerSoc

[IBC Research Fdn @IBCResearch]

Great session on Patient-Centric Drug Development:Lessons learned from Covid. @VivekSubbiah #AAADV21 Workshop.

[AAADV Workshop @AAADV_Workshop]

Thank you to all presenters, moderators, and keynote speaker @califf001 for another successful day of #AAADV2021! #DiversityAndInclusion in #ClinicalTrials, #Pharmacokinetics, and #Biosimilars were just a few topics that were discussed. More engaging discussions to come tomorrow!

[AAADV Workshop @AAADV_Workshop]

Thank you to all presenters, moderators, and keynote speaker @califf001 for another successful day of #AAADV2021! #DiversityAndInclusion in #ClinicalTrials, #Pharmacokinetics, and #Biosimilars were just a few topics that were discussed. More engaging discussions to come tomorrow!

[Richard Schilsky @rschilsky]

Another great day at the @AAADV_Workshop with a fabulous keynote by former FDA Commissioner @califf001. Looking forward to tomorrow’s keynote by Sir Richard Peto and closing remarks by @DavidFajgenbaum.

[AAADV Workshop @AAADV_Workshop]

Your engaging presentation at today's #AAADV workshop brought to light several important aspects of IO safety trials. Honored to have you all at the 17th annual @AAADV_Workshop! @DrJNaidoo @EladSharonMD @HTawbi_MD @kreynoldsMD

[AAADV Workshop @AAADV_Workshop]

Honored to have @DrOlaLandgren present at the 17th annual @AAADV_Workshop! Tune in tomorrow 9/30 to hear @DrOlaLandgren speak on Measurable Residual Disease (MRD) and pathologic Complete Response (pCR). #AAADV #AAADV2021